BE640639A - - Google Patents

Info

Publication number
BE640639A
BE640639A BE640639A BE640639A BE640639A BE 640639 A BE640639 A BE 640639A BE 640639 A BE640639 A BE 640639A BE 640639 A BE640639 A BE 640639A BE 640639 A BE640639 A BE 640639A
Authority
BE
Belgium
Application number
BE640639A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE640639A publication Critical patent/BE640639A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Paper (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
BE640639A 1962-12-01 1963-11-29 BE640639A (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1414962 1962-12-01

Publications (1)

Publication Number Publication Date
BE640639A true BE640639A (en:Method) 1964-05-29

Family

ID=4398397

Family Applications (1)

Application Number Title Priority Date Filing Date
BE640639A BE640639A (en:Method) 1962-12-01 1963-11-29

Country Status (3)

Country Link
AT (1) AT258875B (en:Method)
BE (1) BE640639A (en:Method)
GB (1) GB1072118A (en:Method)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4664848A (en) 1982-12-23 1987-05-12 The Procter & Gamble Company Detergent compositions containing cationic compounds having clay soil removal/anti-redeposition properties
CN101346468B (zh) 2005-06-15 2016-03-30 麻省理工学院 含胺脂质和其用途
MX353900B (es) 2008-11-07 2018-02-01 Massachusetts Inst Technology Lipidoides de aminoalcohol y usos de los mismos.
RS57314B1 (sr) 2009-12-01 2018-08-31 Translate Bio Inc Isporuka irnk za povećanje ekspresije proteina i enzima u humanim genetskim oboljenjima
EP2609135A4 (en) 2010-08-26 2015-05-20 Massachusetts Inst Technology POLY (BETA AMINO ALCOHOLS), THEIR PREPARATION AND USES THEREOF
US9238716B2 (en) 2011-03-28 2016-01-19 Massachusetts Institute Of Technology Conjugated lipomers and uses thereof
IL307511A (en) 2011-06-08 2023-12-01 Shire Human Genetic Therapies Lipid nanoparticle compositions and methods for mrna delivery
WO2013185067A1 (en) 2012-06-08 2013-12-12 Shire Human Genetic Therapies, Inc. Nuclease resistant polynucleotides and uses thereof
WO2014028487A1 (en) 2012-08-13 2014-02-20 Massachusetts Institute Of Technology Amine-containing lipidoids and uses thereof
AU2014236305B2 (en) 2013-03-14 2019-01-17 Ethris Gmbh CFTR mRNA compositions and related methods and uses
EA201591229A1 (ru) 2013-03-14 2016-01-29 Шир Хьюман Дженетик Терапис, Инк. Способы очистки матричной рнк
US9315472B2 (en) 2013-05-01 2016-04-19 Massachusetts Institute Of Technology 1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
NZ718817A (en) 2013-10-22 2020-07-31 Massachusetts Inst Technology Lipid formulations for delivery of messenger rna
BR112016009014B1 (pt) 2013-10-22 2024-02-06 Translate Bio, Inc USO DE COMPOSIÇÃO COMPREENDENDO mRNA PARA DEFICIÊNCIA DE ARGININOSSUCINATO SINTETASE
EP3574923A1 (en) 2013-10-22 2019-12-04 Translate Bio, Inc. Mrna therapy for phenylketonuria
SG11201608725YA (en) 2014-04-25 2016-11-29 Shire Human Genetic Therapies Methods for purification of messenger rna
CA3211902A1 (en) 2014-05-30 2015-12-03 Translate Bio, Inc. Biodegradable lipids for delivery of nucleic acids
EA033966B1 (ru) 2014-06-24 2019-12-13 Транслейт Био, Инк. Стереохимически обогащенные композиции для доставки нуклеиновых кислот
WO2016004202A1 (en) 2014-07-02 2016-01-07 Massachusetts Institute Of Technology Polyamine-fatty acid derived lipidoids and uses thereof
US11253605B2 (en) 2017-02-27 2022-02-22 Translate Bio, Inc. Codon-optimized CFTR MRNA
ES2993135T3 (en) 2017-05-16 2024-12-23 Translate Bio Inc Codon-optimized mrna encoding cftr for use in treating cystic fibrosis
WO2020041793A1 (en) 2018-08-24 2020-02-27 Translate Bio, Inc. Methods for purification of messenger rna
CA3120647A1 (en) 2018-11-21 2020-05-28 Translate Bio, Inc. Treatment of cystic fibrosis by delivery of nebulized mrna encoding cftr

Also Published As

Publication number Publication date
AT258875B (de) 1967-12-11
GB1072118A (en) 1967-06-14

Similar Documents

Publication Publication Date Title
BE627284A (en:Method)
BE633178A (en:Method)
BE618790A (en:Method)
BE620003A (en:Method)
BE620230A (en:Method)
BE620371A (en:Method)
BE620589A (en:Method)
BE621469A (en:Method)
BE621553A (en:Method)
BE621996A (en:Method)
BE622761A (en:Method)
BE622801A (en:Method)
BE622995A (en:Method)
BE623747A (en:Method)
BE623911A (en:Method)
BE624357A (en:Method)
BE624790A (en:Method)
BE624894A (en:Method)
BE624942A (en:Method)
BE625012A (en:Method)
BE625027A (en:Method)
BE625650A (en:Method)
BE625718A (en:Method)
BE625746A (en:Method)
BE627263A (en:Method)